TARDIVE-DYSKINESIA ASSOCIATED WITH METOCLOPRAMIDE

被引：72

作者：

LAVY, S ^{[1
]}

MELAMED, E ^{[1
]}

PENCHAS, S ^{[1
]}

机构：

[1] HADASSAH UNIV HOSP & MED SCH,INTERNAL MED DEPT A,JERUSALEM,ISRAEL

来源：

BRITISH MEDICAL JOURNAL | 1978年 / 1卷 / 6105期

关键词：

D O I：

10.1136/bmj.1.6105.77

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：77 / 78

页数：2

共 7 条

[1]

COCHLIN DL, 1974, BRIT J CLIN PRACT, V28, P201

[2]

CRANE GE, 1972, AM J PSYCHIATRY, V129, P446

[3] PHARMACOLOGICAL EVIDENCE FOR CEREBRAL DOPAMINE RECEPTOR BLOCKADE BY METOCLOPRAMIDE IN RODENTS [J].

DOLPHIN, A ;

JENNER, P ;

MARSDEN, CD ;

PYCOCK, C ;

TARSY, D .

PSYCHOPHARMACOLOGIA, 1975, 41 (02) :133-138

[4] PHARMACOLOGY OF TARDIVE DYSKINESIAS [J].

KLAWANS, HL .

AMERICAN JOURNAL OF PSYCHIATRY, 1973, 130 (01) :82-86

[5] METOCLOPRAMIDE AND FACIAL DYSKINESIA [J].

MELMED, S ;

BANK, H .

BRITISH MEDICAL JOURNAL, 1975, 1 (5953) :331-331

[6] METOCLOPRAMIDE - REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL USE [J].

PINDER, RM ;

BROGDEN, RN ;

SAWYER, PR ;

SPEIGHT, TM ;

AVERY, GS .

DRUGS, 1976, 12 (02) :81-131

[7]

VANDAELE MC, 1970, ARCH DIS CHILD, V45, P130

← 1 →